0001213900-20-007672.txt : 20200327
0001213900-20-007672.hdr.sgml : 20200327
20200327160511
ACCESSION NUMBER: 0001213900-20-007672
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200325
FILED AS OF DATE: 20200327
DATE AS OF CHANGE: 20200327
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Amusa Gbolahan
CENTRAL INDEX KEY: 0001761120
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38762
FILM NUMBER: 20751787
MAIL ADDRESS:
STREET 1: 17 STATE STREET 21 FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10004
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BiomX Inc.
CENTRAL INDEX KEY: 0001739174
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 17 STATE STREET, 16TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10004
BUSINESS PHONE: 646-465-9000
MAIL ADDRESS:
STREET 1: 17 STATE STREET, 16TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10004
FORMER COMPANY:
FORMER CONFORMED NAME: Chardan Healthcare Acquisition Corp.
DATE OF NAME CHANGE: 20180430
4
1
ownership.xml
OWNERSHIP DOCUMENT
X0306
4
2020-03-25
0
0001739174
BiomX Inc.
PHGE
0001761120
Amusa Gbolahan
C/O BIOMX LTD.
7 PINHAS SAPIR ST., FLOOR 2
NESS ZIONA
L3
7414002
ISRAEL
1
0
0
0
Common Stock Options - Right to Buy
6.21
2020-03-25
4
A
0
16000
0
A
2030-03-25
Common Stock
16000
16000
D
The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on March 25, 2021, and the remainder vesting in 12 equal quarterly installments over three years.
/s/ Gbola Amusa
2020-03-27